Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: John O'Neill who wrote (19973)	5/3/1998 9:46:00 PM
From: jayhawk969	Respond to of 32384

JO, I would like the expected NDA will have a more or less permanent effect on the stock and take it to the $20 level. However I don't think so. I think some of it has already been counted, with the stock now basing at $14. I'm in this for the long term, however, I have some set aside as trading stock. If we get a great bump I'll sell some and hold the rest. It will take more than the NDA. By the way, what happened to the Lily drug decision? Shouldn't that have been made by now?

To: John O'Neill who wrote (19973)	5/3/1998 10:10:00 PM
From: Hippieslayer	Respond to of 32384

I'm very concerned that LGND will wallow in a narrow trading range until they show + earnings. There really isn't anything that will move the stock besides that. Pipeline, shmipeline. If analysts really cared about lgnd's pipeline, they'd be all over the stock. LGND has, unfortunately , picked a drug that is of little use to the majority of the public. Other's will spin this story till you can't see straight, but we are at the same juncture we were 2 years ago! LGND has been a trading stock. For us long termers, we just have to put up with all the stupid posts and thick spin till Lgnd finally turns the corner to profitablitly.